mEYEstro simplifies refractive surgery outcome analysis
Click Here to Manage Email Alerts
The need for precise and standardized reporting of surgical outcomes is paramount.
Recognizing this, we developed mEYEstro, an innovative, user-friendly software designed to automate and standardize the reporting of refractive surgery outcomes. This groundbreaking tool addresses the limitations of existing options, providing an accessible solution for all clinicians, surgeons and researchers worldwide.
Source: Mathieu Gauvin, BEng, PhD, and Avi Wallerstein, MD, FRCSC
The genesis of mEYEstro
The concept of mEYEstro was born out of necessity because we observed a significant gap in the tools available for refractive surgery outcome analysis. Existing software solutions were often not free, required cumbersome manual data entry or lacked comprehensive functionality such as automated statistical analyses. The idea was to create a free, stand-alone application that automates the generation of standardized refractive surgery graphs and performs statistical analyses with minimal user input. The result is mEYEstro, a tool that democratizes access to powerful data analytics, making it available to all practitioners, regardless of their budget or institutional resources.
Core functionality
mEYEstro’s primary strength lies in its ability to produce the 11 standard graphs that cover efficacy, safety, accuracy and stability of refractive surgery procedures. These graphs include cumulative uncorrected and corrected distance visual acuity, changes in corrected distance visual acuity, spherical equivalent accuracy, defocus equivalent accuracy and astigmatism accuracy, among others. The software automatically calculates percent proportions, means, standard deviations, effect sizes and P values for each graph, which can be easily exported as high-resolution images suitable for scientific manuscripts and presentations.
The software’s workflow is straightforward. Users select the type of refractive surgery, the type of study, group names and graph colors before uploading their data in an Excel table. mEYEstro then automatically generates and saves the required graphs and statistical analyses, streamlining the entire process and significantly reducing the potential for user error.
To measure is to improve
The benefits of mEYEstro extend beyond academic research. For clinicians and surgeons, the software offers the ability for a deeper understanding of surgical outcomes, enabling evidence-based decisions to optimize patient care. The detailed scattergrams for attempted vs. achieved corrections allow for precise nomogram creation, helping surgeons adjust surgical parameters to improve predictability and success rates. This tool is especially valuable for quality assurance and personalized patient care, providing real-world data that can be shared with patients to inform and guide their treatment decisions.
mEYEstro enables surgeons to perform consecutive sampling for quality assurance, ensuring outcomes are as expected and identifying areas for improvement. This is particularly helpful for high-volume surgeons who need to monitor trends over time efficiently and modify their nomograms accordingly.
Overcoming development challenges
Developing mEYEstro was not without its challenges. Ensuring the software could perform accurate and automated statistical analyses, generate high-resolution graphs and maintain data security were significant priorities. Rigorous testing and feedback from beta users were crucial in refining the software. The result is a robust, reliable and fast tool that meets the needs of the ophthalmic community.
Future developments
mEYEstro is designed to evolve with the needs of its users. Future updates are planned to include advanced enhancement analyses, direct logMAR data entry and web-based functionality. These updates will further enhance the software’s capability to provide comprehensive and precise refractive surgery outcome analyses. The development team is committed to continuous improvement, inviting user feedback to guide future updates and ensure the software remains at the cutting edge of ophthalmic data analysis.
Ensuring data security
mEYEstro was built with a focus on data security. As a stand-alone application, it operates locally on the user’s computer, ensuring that all data remain private and secure. The developers have no visibility into the data input by users, and the software does not store data on any external servers or cloud services and can be used offline. This local operation model helps maintain patient confidentiality and data integrity, a critical consideration in medical research and clinical practice.
Conclusion
mEYEstro represents a significant advancement in the field of refractive surgery outcome analysis. By automating the generation of standardized graphs and performing rigorous statistical analyses, it simplifies and enhances the accuracy of data reporting. This tool is set to become an essential asset in both academic research and clinical practice, helping ophthalmologists worldwide improve their understanding and presentation of surgical outcomes. With mEYEstro, we have created a tool that not only meets current needs but also sets a new standard for the future of ophthalmic data analysis. For more information and to download the software, visit www.refractivesurgery.ca or www.lasikmd.com/media/meyestro/index.php.
- For more information:
- Mathieu Gauvin, BEng, PhD, an affiliate member of ophthalmology and visual sciences and research scientist in the refractive surgery research unit at McGill University, an associate professor of electrical engineering (health) at École de Technologie Supérieure, and head of research and development at Vision Group and LASIK MD in Montreal, can be reached at mathieu.gauvin@mcgill.ca.
- Avi Wallerstein, MD, FRCSC, head of refractive surgery and assistant professor of ophthalmology at McGill University and executive vice president and co-national medical director at Vision Group and LASIK MD in Montreal, can be reached at avi.wallerstein@mcgill.ca.
Collapse
Read more about
Click Here to Manage Email Alerts